Show simple item record

dc.contributor.authorSlack, Jessica L.
dc.contributor.authorCausey, Corey P.
dc.contributor.authorLuo, Yuan
dc.contributor.authorThompson, Paul R
dc.date2022-08-11T08:11:00.000
dc.date.accessioned2022-08-23T17:28:15Z
dc.date.available2022-08-23T17:28:15Z
dc.date.issued2011-05-20
dc.date.submitted2015-05-22
dc.identifier.citationACS Chem Biol. 2011 May 20;6(5):466-76. doi: 10.1021/cb1003515. Epub 2011 Feb 7. <a href="http://dx.doi.org/10.1021/cb1003515">Link to article on publisher's site</a>
dc.identifier.issn1554-8929 (Linking)
dc.identifier.doi10.1021/cb1003515
dc.identifier.urihttp://hdl.handle.net/20.500.14038/50040
dc.description<p>At the time of publication, Paul Thompson was not yet affiliated with UMass Medical School.</p>
dc.description.abstractThe protein arginine deiminases (PADs), which catalyze the hydrolysis of peptidyl-arginine to form peptidyl-citrulline, are potential targets for the development of a rheumatoid arthritis (RA) therapeutic, as well as other human diseases including colitis and cancer. Additionally, these enzymes, and in particular PAD4, appear to play important roles in a variety of cell signaling pathways including apoptosis, differentiation, and transcriptional regulation. To better understand the factors that regulate in vivo PAD4 activity, we set out to design and synthesize a series of activity-based protein profiling (ABPP) reagents that target this enzyme. Herein we describe the design, synthesis, and evaluation of six ABPPs including (i) FITC-conjugated F-amidine (FFA1 and 2) and Cl-amidine (FCA1 and 2), and (ii) biotin-conjugated F-amidine (BFA) and Cl-amidine (BCA). We further demonstrate the utility of these probes for labeling PAD4 in cells, as well as for isolating PAD4 and PAD4 binding proteins. These probes will undoubtedly prove to be powerful tools that can be used to dissect the factors controlling the dynamics of PAD4 expression, activity, and function.
dc.language.isoen_US
dc.relation<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=21265574&dopt=Abstract">Link to Article in PubMed</a>
dc.relation.urlhttp://www.ncbi.nlm.nih.gov/pmc/articles/PMC3098906/
dc.subjectAmidines
dc.subjectBiotin
dc.subjectEnzyme Activation
dc.subjectFluorescent Dyes
dc.subjectHumans
dc.subjectHydrolases
dc.subjectLimit of Detection
dc.subjectProtein Array Analysis
dc.subjectTriazoles
dc.subjectBiochemistry
dc.subjectEnzymes and Coenzymes
dc.subjectMedicinal-Pharmaceutical Chemistry
dc.subjectTherapeutics
dc.titleDevelopment and use of clickable activity based protein profiling agents for protein arginine deiminase 4.
dc.typeJournal Article
dc.source.journaltitleACS chemical biology
dc.source.volume6
dc.source.issue5
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/thompson/49
dc.identifier.contextkey7135718
html.description.abstract<p>The protein arginine deiminases (PADs), which catalyze the hydrolysis of peptidyl-arginine to form peptidyl-citrulline, are potential targets for the development of a rheumatoid arthritis (RA) therapeutic, as well as other human diseases including colitis and cancer. Additionally, these enzymes, and in particular PAD4, appear to play important roles in a variety of cell signaling pathways including apoptosis, differentiation, and transcriptional regulation. To better understand the factors that regulate in vivo PAD4 activity, we set out to design and synthesize a series of activity-based protein profiling (ABPP) reagents that target this enzyme. Herein we describe the design, synthesis, and evaluation of six ABPPs including (i) FITC-conjugated F-amidine (FFA1 and 2) and Cl-amidine (FCA1 and 2), and (ii) biotin-conjugated F-amidine (BFA) and Cl-amidine (BCA). We further demonstrate the utility of these probes for labeling PAD4 in cells, as well as for isolating PAD4 and PAD4 binding proteins. These probes will undoubtedly prove to be powerful tools that can be used to dissect the factors controlling the dynamics of PAD4 expression, activity, and function.</p>
dc.identifier.submissionpaththompson/49
dc.contributor.departmentDepartment of Biochemistry and Molecular Pharmacology
dc.source.pages466-76


This item appears in the following Collection(s)

Show simple item record